BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Now, Recaf did allow one to catch a cancer early enough to make a decision to have a biopsy.

Question #1. Did the biopsy occur?

Answer #1 = no....Then shame on the patient.

Answer #1 = Yes ...Then what is the result?

Question #2. Is cancer present?

Answer #1 = Yes...or Answer #2 = No.

One must currently stop here as far as Recaf is concerned !!!

Recaf performed its screening function and did a better job at it than any other test on the market.

Any further treatment is completely up to the patient.

We do not know if the cancer is fast or slow growing. We did not even know this with the current PSA or DRE so why place this burden on Recaf?

Even the Gleason test can't tell one this The Gleason score is far from conclusive;

Now. We have given the patient one critical answer and in a timely manner when there is still hope.

Step #1. Determine if cancer is present.